Why the study?
Does exenatide at the time of primary PCI improve long-term prognosis in patients with STEMI?
Population
Patients with ST-segment elevation myocardial infarction (STEMI)
Design
Cohort
Follow-up
long-term
Authors
Loading...
Exenatide at primary PCI should not alter STEMI management; hypothesis-generating for reduced heart failure admissions in prospective trials.
Does exenatide at the time of primary PCI improve long-term prognosis in patients with STEMI?
In patients with STEMI undergoing primary PCI, exenatide did not improve the primary composite endpoint or mortality, but may reduce heart failure admissions.
Kyhl et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: